200 related articles for article (PubMed ID: 7485401)
1. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas.
Moll R; Wu XR; Lin JH; Sun TT
Am J Pathol; 1995 Nov; 147(5):1383-97. PubMed ID: 7485401
[TBL] [Abstract][Full Text] [Related]
2. [Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas].
Moll R; Laufer J; Wu XR; Sun TT
Verh Dtsch Ges Pathol; 1993; 77():260-5. PubMed ID: 7511294
[TBL] [Abstract][Full Text] [Related]
3. Differential immunocytochemical staining patterns of uroplakin observed on neoplastic and nonneoplastic tissue fragments obtained from upper urinary tract brush specimens.
Xu X; Genega EM; Nasuti JF
Acta Cytol; 2002; 46(4):684-9. PubMed ID: 12146031
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and expression of uroplakins in transitional cell carcinoma.
Yuasa T; Yoshiki T; Isono T; Tanaka T; Okada Y
Adv Exp Med Biol; 2003; 539(Pt A):33-46. PubMed ID: 15088894
[TBL] [Abstract][Full Text] [Related]
5. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas.
Kaufmann O; Volmerig J; Dietel M
Am J Clin Pathol; 2000 May; 113(5):683-7. PubMed ID: 10800401
[TBL] [Abstract][Full Text] [Related]
6. Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine-needle aspiration specimens.
Xu X; Sun TT; Gupta PK; Zhang P; Nasuti JF
Cancer; 2001 Jun; 93(3):216-21. PubMed ID: 11391610
[TBL] [Abstract][Full Text] [Related]
7. Uroplakin gene expression by normal and neoplastic human urothelium.
Lobban ED; Smith BA; Hall GD; Harnden P; Roberts P; Selby PJ; Trejdosiewicz LK; Southgate J
Am J Pathol; 1998 Dec; 153(6):1957-67. PubMed ID: 9846985
[TBL] [Abstract][Full Text] [Related]
8. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
9. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
[TBL] [Abstract][Full Text] [Related]
10. High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma.
Kageyama S; Yoshiki T; Isono T; Tanaka T; Kim CJ; Yuasa T; Okada Y
Jpn J Cancer Res; 2002 May; 93(5):523-31. PubMed ID: 12036448
[TBL] [Abstract][Full Text] [Related]
11. Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?
Riedel I; Liang FX; Deng FM; Tu L; Kreibich G; Wu XR; Sun TT; Hergt M; Moll R
Eur J Cell Biol; 2005 Mar; 84(2-3):393-405. PubMed ID: 15819416
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
[TBL] [Abstract][Full Text] [Related]
13. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
14. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation.
Wu RL; Osman I; Wu XR; Lu ML; Zhang ZF; Liang FX; Hamza R; Scher H; Cordon-Cardo C; Sun TT
Cancer Res; 1998 Mar; 58(6):1291-7. PubMed ID: 9515818
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
Li SM; Zhang ZT; Chan S; McLenan O; Dixon C; Taneja S; Lepor H; Sun TT; Wu XR
J Urol; 1999 Sep; 162(3 Pt 1):931-5. PubMed ID: 10458411
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract.
Ogawa K; Johansson SL; Cohen SM
Am J Pathol; 1999 Oct; 155(4):1047-50. PubMed ID: 10514386
[TBL] [Abstract][Full Text] [Related]
17. Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome.
Huang HY; Shariat SF; Sun TT; Lepor H; Shapiro E; Hsieh JT; Ashfaq R; Lotan Y; Wu XR
Hum Pathol; 2007 Nov; 38(11):1703-13. PubMed ID: 17707461
[TBL] [Abstract][Full Text] [Related]
18. Needle aspiration cytology of metastatic high-grade transitional-cell carcinomas of the urinary tract.
Ho CC; Nguyen GK; Schumann GB
Diagn Cytopathol; 1998 Jun; 18(6):409-15. PubMed ID: 9626512
[TBL] [Abstract][Full Text] [Related]
19. Expression of uroplakin Ib and uroplakin III genes in tissues and peripheral blood of patients with transitional cell carcinoma.
Yuasa T; Yoshiki T; Tanaka T; Kim CJ; Isono T; Okada Y
Jpn J Cancer Res; 1998 Sep; 89(9):879-82. PubMed ID: 9818021
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.
Osman I; Kang M; Lee A; Deng FM; Polsky D; Mikhail M; Chang C; David DA; Mitra N; Wu XR; Sun TT; Bajorin DF
Int J Cancer; 2004 Oct; 111(6):934-9. PubMed ID: 15300806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
